Kala Bio KALA
NASDAQ KALA
$0.16 +0.01 (+3.73%)
As of: Nov 9, 2026 · 9:30 AM EST

Kala Bio (KALA) Amortization of Deferred Charges (2016 - 2025)

Updated

Analysis

Kala Bio (KALA) Amortization of Deferred Charges (2016 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Kala Bio 2.38 Mn -42.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.14 Mn
Sep 30, 2025 116,000.00
Jun 30, 2025 173,000.00
Mar 31, 2025 186,000.00
Dec 31, 2024 299,000.00
Sep 30, 2024 322,000.00
Jun 30, 2024 315,000.00
Mar 31, 2024 312,000.00
Dec 31, 2023 312,000.00
Sep 30, 2023 309,000.00
Jun 30, 2023 303,000.00
Mar 31, 2023 329,000.00
Dec 31, 2022 295,000.00
Sep 30, 2022 259,000.00
Jun 30, 2022 439,000.00
Mar 31, 2022 432,000.00
Dec 31, 2021 439,000.00
Sep 30, 2021 435,000.00
Jun 30, 2021 367,000.00
Mar 31, 2021 278,000.00
API Access

Kala Bio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=KALA&period=max&api_key=YOUR_API_KEY